U.S. Pharmaceuticals & Biotech Stable Growth Stocks

Exelixis

Market Cap: US$10.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Catalyst Pharmaceuticals

Market Cap: US$2.6b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Merck

Market Cap: US$214.8b

Operates as a healthcare company worldwide.

Incyte

Market Cap: US$18.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Waters

Market Cap: US$20.8b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Medpace Holdings

Market Cap: US$16.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Stevanato Group

Market Cap: US$6.9b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Halozyme Therapeutics

Market Cap: US$7.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Johnson & Johnson

Market Cap: US$455.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Gilead Sciences

Market Cap: US$148.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Corcept Therapeutics

Market Cap: US$7.7b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Mettler-Toledo International

Market Cap: US$29.2b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Eli Lilly

Market Cap: US$772.6b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Zoetis

Market Cap: US$63.9b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.